Global and United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market
This report focuses on global and United States Human Immunoglobulin for Intravenous Injection, Freeze Dried market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Human Immunoglobulin for Intravenous Injection, Freeze Dried market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Lyophilized Powder accounting for % of the Human Immunoglobulin for Intravenous Injection, Freeze Dried global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Treatment of Primary Immunoglobulin G Deficiency was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Human Immunoglobulin for Intravenous Injection, Freeze Dried market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Scope and Market Size
Human Immunoglobulin for Intravenous Injection, Freeze Dried market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Immunoglobulin for Intravenous Injection, Freeze Dried market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Human Immunoglobulin for Intravenous Injection, Freeze Dried market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Lyophilized Powder
    Injection

Segment by Application
    Treatment of Primary Immunoglobulin G Deficiency
    Treatment of Secondary Immunoglobulin G Deficiency
    Treatment of Autoimmune Diseases

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    BOYA-BIO
    CHENGDURONGSHENG PHARMACEUTICALS CO
    Sinopharm Group Biomedicine Co
    Shanghai RAAS Blood Products Co
    Weiguang Biological Products
    Tiantan Biological
    Tonrol
    Wellen Biological Pharmaceutical

 1 Study Coverage
    1.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Product Introduction
    1.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume for the Year 2017-2028
    1.3 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume for the Year 2017-2028
    1.4 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Human Immunoglobulin for Intravenous Injection, Freeze Dried in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Dynamics
        1.5.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Industry Trends
        1.5.2 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Drivers
        1.5.3 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Challenges
        1.5.4 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Segment by Type
        2.1.1 Lyophilized Powder
        2.1.2 Injection
    2.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Type
        2.2.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Type
        2.3.1 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Segment by Application
        3.1.1 Treatment of Primary Immunoglobulin G Deficiency
        3.1.2 Treatment of Secondary Immunoglobulin G Deficiency
        3.1.3 Treatment of Autoimmune Diseases
    3.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Application
        3.2.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Application
        3.3.1 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Competitor Landscape by Company
    4.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Company
        4.1.1 Top Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue by Manufacturer (2017-2022)
        4.1.3 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Manufacturer (2017-2022)
        4.1.4 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Price by Manufacturer (2017-2022)
    4.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Concentration Ratio (CR)
        4.2.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Immunoglobulin for Intravenous Injection, Freeze Dried in 2021
        4.2.3 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Manufacturing Base Distribution, Product Type
        4.3.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Human Immunoglobulin for Intravenous Injection, Freeze Dried Product Type
        4.3.3 Date of International Manufacturers Enter into Human Immunoglobulin for Intravenous Injection, Freeze Dried Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Company
        4.5.1 Top Human Immunoglobulin for Intravenous Injection, Freeze Dried Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Players (2020, 2021 & 2022)

 5 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Region
    5.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size in Volume by Region (2017-2028)
        5.2.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Region: 2017-2022
        5.2.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size in Value by Region (2017-2028)
        5.3.1 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Region: 2017-2022
        5.3.2 Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size YoY Growth 2017-2028
        6.1.2 North America Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size YoY Growth 2017-2028
        6.3.2 Europe Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size YoY Growth 2017-2028
        6.4.2 Latin America Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 BOYA-BIO
        7.1.1 BOYA-BIO Corporation Information
        7.1.2 BOYA-BIO Description and Business Overview
        7.1.3 BOYA-BIO Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 BOYA-BIO Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.1.5 BOYA-BIO Recent Development
    7.2 CHENGDURONGSHENG PHARMACEUTICALS CO
        7.2.1 CHENGDURONGSHENG PHARMACEUTICALS CO Corporation Information
        7.2.2 CHENGDURONGSHENG PHARMACEUTICALS CO Description and Business Overview
        7.2.3 CHENGDURONGSHENG PHARMACEUTICALS CO Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 CHENGDURONGSHENG PHARMACEUTICALS CO Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.2.5 CHENGDURONGSHENG PHARMACEUTICALS CO Recent Development
    7.3 Sinopharm Group Biomedicine Co
        7.3.1 Sinopharm Group Biomedicine Co Corporation Information
        7.3.2 Sinopharm Group Biomedicine Co Description and Business Overview
        7.3.3 Sinopharm Group Biomedicine Co Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sinopharm Group Biomedicine Co Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.3.5 Sinopharm Group Biomedicine Co Recent Development
    7.4 Shanghai RAAS Blood Products Co
        7.4.1 Shanghai RAAS Blood Products Co Corporation Information
        7.4.2 Shanghai RAAS Blood Products Co Description and Business Overview
        7.4.3 Shanghai RAAS Blood Products Co Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Shanghai RAAS Blood Products Co Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.4.5 Shanghai RAAS Blood Products Co Recent Development
    7.5 Weiguang Biological Products
        7.5.1 Weiguang Biological Products Corporation Information
        7.5.2 Weiguang Biological Products Description and Business Overview
        7.5.3 Weiguang Biological Products Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Weiguang Biological Products Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.5.5 Weiguang Biological Products Recent Development
    7.6 Tiantan Biological
        7.6.1 Tiantan Biological Corporation Information
        7.6.2 Tiantan Biological Description and Business Overview
        7.6.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.6.5 Tiantan Biological Recent Development
    7.7 Tonrol
        7.7.1 Tonrol Corporation Information
        7.7.2 Tonrol Description and Business Overview
        7.7.3 Tonrol Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Tonrol Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.7.5 Tonrol Recent Development
    7.8 Wellen Biological Pharmaceutical
        7.8.1 Wellen Biological Pharmaceutical Corporation Information
        7.8.2 Wellen Biological Pharmaceutical Description and Business Overview
        7.8.3 Wellen Biological Pharmaceutical Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Wellen Biological Pharmaceutical Human Immunoglobulin for Intravenous Injection, Freeze Dried Products Offered
        7.8.5 Wellen Biological Pharmaceutical Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Industry Chain Analysis
    8.2 Human Immunoglobulin for Intravenous Injection, Freeze Dried Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Human Immunoglobulin for Intravenous Injection, Freeze Dried Distributors
    8.3 Human Immunoglobulin for Intravenous Injection, Freeze Dried Production Mode & Process
    8.4 Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales and Marketing
        8.4.1 Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Channels
        8.4.2 Human Immunoglobulin for Intravenous Injection, Freeze Dried Distributors
    8.5 Human Immunoglobulin for Intravenous Injection, Freeze Dried Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Human Immunoglobulin for Intravenous Injection, Freeze Dried CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Trends
    Table 3. Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Drivers
    Table 4. Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Challenges
    Table 5. Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Restraints
    Table 6. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Immunoglobulin for Intravenous Injection, Freeze Dried Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunoglobulin for Intravenous Injection, Freeze Dried as of 2021)
    Table 18. Top Players of Human Immunoglobulin for Intravenous Injection, Freeze Dried in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Immunoglobulin for Intravenous Injection, Freeze Dried Product Type
    Table 20. Date of International Manufacturers Enter into Human Immunoglobulin for Intravenous Injection, Freeze Dried Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Immunoglobulin for Intravenous Injection, Freeze Dried Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BOYA-BIO Corporation Information
    Table 43. BOYA-BIO Description and Business Overview
    Table 44. BOYA-BIO Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. BOYA-BIO Human Immunoglobulin for Intravenous Injection, Freeze Dried Product
    Table 46. BOYA-BIO Recent Development
    Table 47. CHENGDURONGSHENG PHARMACEUTICALS CO Corporation Information
    Table 48. CHENGDURONGSHENG PHARMACEUTICALS CO Description and Business Overview
    Table 49. CHENGDURONGSHENG PHARMACEUTICALS CO Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. CHENGDURONGSHENG PHARMACEUTICALS CO Product
    Table 51. CHENGDURONGSHENG PHARMACEUTICALS CO Recent Development
    Table 52. Sinopharm Group Biomedicine Co Corporation Information
    Table 53. Sinopharm Group Biomedicine Co Description and Business Overview
    Table 54. Sinopharm Group Biomedicine Co Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Sinopharm Group Biomedicine Co Product
    Table 56. Sinopharm Group Biomedicine Co Recent Development
    Table 57. Shanghai RAAS Blood Products Co Corporation Information
    Table 58. Shanghai RAAS Blood Products Co Description and Business Overview
    Table 59. Shanghai RAAS Blood Products Co Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Shanghai RAAS Blood Products Co Product
    Table 61. Shanghai RAAS Blood Products Co Recent Development
    Table 62. Weiguang Biological Products Corporation Information
    Table 63. Weiguang Biological Products Description and Business Overview
    Table 64. Weiguang Biological Products Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Weiguang Biological Products Product
    Table 66. Weiguang Biological Products Recent Development
    Table 67. Tiantan Biological Corporation Information
    Table 68. Tiantan Biological Description and Business Overview
    Table 69. Tiantan Biological Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Tiantan Biological Product
    Table 71. Tiantan Biological Recent Development
    Table 72. Tonrol Corporation Information
    Table 73. Tonrol Description and Business Overview
    Table 74. Tonrol Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Tonrol Product
    Table 76. Tonrol Recent Development
    Table 77. Wellen Biological Pharmaceutical Corporation Information
    Table 78. Wellen Biological Pharmaceutical Description and Business Overview
    Table 79. Wellen Biological Pharmaceutical Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Wellen Biological Pharmaceutical Product
    Table 81. Wellen Biological Pharmaceutical Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Human Immunoglobulin for Intravenous Injection, Freeze Dried Customers List
    Table 85. Human Immunoglobulin for Intravenous Injection, Freeze Dried Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Immunoglobulin for Intravenous Injection, Freeze Dried Product Picture
    Figure 2. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales 2017-2028 (K Units)
    Figure 5. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales 2017-2028 (K Units)
    Figure 8. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Human Immunoglobulin for Intravenous Injection, Freeze Dried Report Years Considered
    Figure 11. Product Picture of Lyophilized Powder
    Figure 12. Product Picture of Injection
    Figure 13. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share by Type in 2022 & 2028
    Figure 14. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share by Type in 2022 & 2028
    Figure 20. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Treatment of Primary Immunoglobulin G Deficiency
    Figure 26. Product Picture of Treatment of Secondary Immunoglobulin G Deficiency
    Figure 27. Product Picture of Treatment of Autoimmune Diseases
    Figure 28. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share by Application in 2022 & 2028
    Figure 29. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Share by Application in 2022 & 2028
    Figure 35. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Human Immunoglobulin for Intravenous Injection, Freeze Dried Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Human Immunoglobulin for Intravenous Injection, Freeze Dried Value Chain
    Figure 73. Human Immunoglobulin for Intravenous Injection, Freeze Dried Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed

Market Analysis and Insights: Global and United States Human Immunoglobulin for Intravenous Injection, Freeze Dried Market
This report focuses on global and United States Human Immunoglobulin for Intravenous Injection, Freeze Dried market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Human Immunoglobulin for Intravenous Injection, Freeze Dried market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Lyophilized Powder accounting for % of the Human Immunoglobulin for Intravenous Injection, Freeze Dried global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Treatment of Primary Immunoglobulin G Deficiency was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Human Immunoglobulin for Intravenous Injection, Freeze Dried market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Scope and Market Size
Human Immunoglobulin for Intravenous Injection, Freeze Dried market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Immunoglobulin for Intravenous Injection, Freeze Dried market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Human Immunoglobulin for Intravenous Injection, Freeze Dried market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Lyophilized Powder
    Injection

Segment by Application
    Treatment of Primary Immunoglobulin G Deficiency
    Treatment of Secondary Immunoglobulin G Deficiency
    Treatment of Autoimmune Diseases

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    BOYA-BIO
    CHENGDURONGSHENG PHARMACEUTICALS CO
    Sinopharm Group Biomedicine Co
    Shanghai RAAS Blood Products Co
    Weiguang Biological Products
    Tiantan Biological
    Tonrol
    Wellen Biological Pharmaceutical